WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Cerrar esta carpetaSubcutaneous fungal infections
Ver el documentoSporotrichosis
Ver el documentoMycetoma
Ver el documentoChromomycosis
Ver el documentoSubcutaneous zygomycosis
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Sporotrichosis

Cutaneous sporotrichosis, which is caused by Sporothrix schenckii, presents as a nodular or pustular lesion which later ulcerates to form a chancre. After several weeks or months multiple painless subcutaneous nodules appear, indicating that lymphatic involvement has occurred.

Treatment

The infection is usually cured by oral treatment with a saturated solution of potassium iodide (1 g/ml). Treatment should be started with a dosage of five drops three times daily and increased by one drop per dose up to a maximum of 30-40 drops three times daily. The drug should be diluted in a glass of fruit juice, milk or water, or taken with food to minimize gastrointestinal side-effects. Treatment should be continued for at least 1 month after all signs have resolved. If signs of iodism occur (e.g. nausea, vomiting, coryza and an acneiform rash) treatment should be temporarily suspended and restarted several days later at lower dosage. Patients who are unable to tolerate potassium iodide should receive itraconazole, 200-400 mg daily.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 19 enero 2012